Changes in plasma lipoprotein levels during medication with a glucoside-hydrolase inhibitor (acarbose).
D020909:Acarbose; D000328:Adult; D002784:Cholesterol / Q000097:blood; D005260:Female; D006026:Glycoside Hydrolases / Q000037:antagonists & inhibitors*; D006801:Humans; D006951:Hyperlipoproteinemias / Q000188:drug therapy; D008074:Lipoproteins / Q000097:blood*; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D009844:Oligosaccharides / Q000494:pharmacology*; D014280:Triglycerides / Q000097:blood; D014312:Trisaccharides / Q000494:pharmacology*
D008074:Lipoproteins; D008079:Lipoproteins, VLDL; D009844:Oligosaccharides; D014280:Triglycerides; D014312:Trisaccharides; D002784:Cholesterol; D006026:Glycoside Hydrolases; D020909:Acarbose